1136 Clinical Trial 2020-1137 Clinical Trial 2020...
View lymphoma clinical trials and multiple myeloma clinical trials being conducted by MD Anderson Cancer Center, a top ranked cancer center.
This is a Phase 1 dose escalation study following a 3+3 study design. The purpose of this study is to evaluate the safety and efficacy of ADI-001 in patients with B cell malignancies.